Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29

Mar 22, 2021 ‐ Mar 24, 2021


Sessions

[Joint Session] Welcoming Remarks and Keynote Session icon[Joint Session] Welcoming Remarks and Keynote Session

Preview Available

[Joint Session] Welcoming Remarks and Keynote Session

Mar 22, 2021 10:00am ‐ Mar 22, 2021 11:10am

Co-Chair(s):
Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers iconChanging Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers

Preview Available

Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers

Mar 22, 2021 10:35am ‐ Mar 22, 2021 11:10am

Speaker(s):
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC iconA TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

Preview Available

A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC

Mar 22, 2021 11:10am ‐ Mar 22, 2021 11:35am

Speaker(s):
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers icon[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Preview Available

[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers

Mar 22, 2021 11:10am ‐ Mar 22, 2021 1:00pm

Co-Chair(s):
The Gut-Liver Axis in Liver Cancer Risk Conditions iconThe Gut-Liver Axis in Liver Cancer Risk Conditions

Preview Available

The Gut-Liver Axis in Liver Cancer Risk Conditions

Mar 22, 2021 11:55am ‐ Mar 22, 2021 12:20pm

Speaker(s):
Lipid Dysregulation in Inflammation, NASH, and Cancer iconLipid Dysregulation in Inflammation, NASH, and Cancer

Preview Available

Lipid Dysregulation in Inflammation, NASH, and Cancer

Mar 22, 2021 12:20pm ‐ Mar 22, 2021 12:45pm

Speaker(s):
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study iconShort Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Preview Available

Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study

Mar 22, 2021 12:45pm ‐ Mar 22, 2021 1:00pm

Speaker(s):
Role of Cancer Associated Fibroblasts in Cholangiocarcinoma iconRole of Cancer Associated Fibroblasts in Cholangiocarcinoma

Preview Available

Role of Cancer Associated Fibroblasts in Cholangiocarcinoma

Mar 22, 2021 5:00pm ‐ Mar 22, 2021 5:30pm

Speaker(s):
Tumor Microenvironment and Hepatobiliary Cancers iconTumor Microenvironment and Hepatobiliary Cancers

Preview Available

Tumor Microenvironment and Hepatobiliary Cancers

Mar 22, 2021 5:00pm ‐ Mar 22, 2021 8:10pm

Co-Chair(s):
Mechanisms of Immune Escape in Hepatocellular Carcinoma iconMechanisms of Immune Escape in Hepatocellular Carcinoma

Preview Available

Mechanisms of Immune Escape in Hepatocellular Carcinoma

Mar 22, 2021 5:30pm ‐ Mar 22, 2021 6:00pm

Speaker(s):